MedTrace Logo

Study of Prednisone, Vinblastine, Doxorubicin, and Gemcitabine in Elderly Patients With Advanced Stages Hodgkin's Lymphoma

NCT00147875 · Status: COMPLETED · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2009-09-07

No results posted yet for this study

Summary

The objectives of this study are to assess the feasibility and efficacy of a combination chemotherapy (PVAG) in elderly patients with advanced stages Hodgkin's lymphoma.

Conditions

  • Hodgkin's Disease

Interventions

DRUG

Prednisone

DRUG

Vinblastine

DRUG

Doxorubicin (Adriamycin)

DRUG

Gemcitabine

Sponsors & Collaborators

  • German Hodgkin's Lymphoma Study Group

    collaborator OTHER

  • Eli Lilly and Company

    collaborator INDUSTRY

  • University of Cologne

    lead OTHER

Principal Investigators

  • Andreas Engert · University of Cologne

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
60 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-03-31
Primary Completion
2007-07-31

Countries

  • Germany

Study Locations

More Related Trials

Entities

Drugs
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00147875 on ClinicalTrials.gov